Spots Global Cancer Trial Database for advanced urothelial carcinoma

Every month we try and update this database with for advanced urothelial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma	NCT05738161	Advanced Urothe...	Magrolimab Cisplatin Gemcitabine	18 Years -	Insel Gruppe AG, University Hospital Bern
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma	NCT01071928	Urothelial Carc...	Docetaxel ASA404	18 Years -	Hoosier Cancer Research Network
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer	NCT03871036	Urothelial Carc...	Tremelimumab Durvalumab Paclitaxel	18 Years -	The Netherlands Cancer Institute
9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer	NCT06079112	Advanced Urothe...	9MW2821 Toripalimab	18 Years - 80 Years	Mabwell (Shanghai) Bioscience Co., Ltd.
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer	NCT04491942	Advanced Bile D... Advanced Breast... Advanced Cervic... Advanced Endome... Advanced Esopha... Advanced Gastri... Advanced Head a... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Ovaria... Advanced Penile... Advanced Pleura... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Stage III Cervi... Stage III Dista... Stage III Intra... Stage III Lung ... Stage III Ovari... Stage III Penil... Stage III Pleur... Stage IV Cervic... Stage IV Distal... Stage IV Intrah... Stage IV Lung C... Stage IV Ovaria... Stage IV Penile... Stage IV Pleura... Triple-Negative... Unresectable Ur...	Cisplatin Elimusertib Gemcitabine Hyd...	18 Years -	National Cancer Institute (NCI)
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV	NCT04514484	Advanced Differ... Advanced Head a... Advanced Hepato... Advanced Kaposi... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Melano... Advanced Ovaria... Advanced Prosta... Advanced Renal ... Advanced Thyroi... Advanced Triple... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HIV Infection Metastatic Diff... Metastatic Head... Metastatic Hepa... Metastatic Kapo... Metastatic Lung... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Pros... Metastatic Rena... Metastatic Thyr... Metastatic Trip... Metastatic Urot... Recurrent Diffe... Recurrent Head ... Recurrent Hepat... Recurrent Kapos... Recurrent Lung ... Recurrent Lung ... Recurrent Malig... Recurrent Melan... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Thyro... Recurrent Tripl... Recurrent Uroth... Refractory Diff... Stage III Diffe... Stage III Hepat... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Thyro... Stage IV Differ... Stage IV Hepato... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Thyroi...	Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer	NCT06196736	Advanced Urothe...	9MW2821 Chemotherapy	18 Years - 75 Years	Mabwell (Shanghai) Bioscience Co., Ltd.
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer	NCT06196736	Advanced Urothe...	9MW2821 Chemotherapy	18 Years - 75 Years	Mabwell (Shanghai) Bioscience Co., Ltd.
Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma	NCT04856189	Advanced Urothe... Locally Advance... Metastatic Urot... Refractory Urot...	Pembrolizumab Selinexor	18 Years -	University of California, Davis
A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma	NCT04603846	Advanced Urothe...	anti-PD-L1 anti... albumin bound p...	18 Years -	Lee's Pharmaceutical Limited
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma	NCT05929235	Advanced Solid ... Advanced Urothe... Oral Drug Admin... Open Label	FX-909	18 Years -	Flare Therapeutics Inc.
Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma	NCT01487915	Advanced Urothe...	GCb GemOx	18 Years -	Asan Medical Center
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	NCT05733000	Advanced Biliar... Advanced Colore... Advanced Gastro... Advanced Lung A... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Urothe... Clinical Stage ... Clinical Stage ... Metastatic Bili... Metastatic Colo... Metastatic Gast... Metastatic Lung... Metastatic Ovar... Metastatic Panc... Metastatic Urot... Refractory Bili... Refractory Colo... Refractory Gast... Refractory Lung... Refractory Ovar... Refractory Panc... Refractory Urot... Stage II Pancre... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Pancr... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Pancre...	Biospecimen Col... Computed Tomogr... Devimistat Fluorouracil Gemcitabine Hyd... Hydroxychloroqu... Magnetic Resona...	18 Years -	Northwestern University
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer	NCT03871036	Urothelial Carc...	Tremelimumab Durvalumab Paclitaxel	18 Years -	The Netherlands Cancer Institute
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction	NCT00365157	Advanced Urothe... Locally Advance... Metastatic Urot... Recurrent Uroth... Stage III Bladd... Stage IV Bladde... Unresectable Ur...	Eribulin Mesyla... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma	NCT04856189	Advanced Urothe... Locally Advance... Metastatic Urot... Refractory Urot...	Pembrolizumab Selinexor	18 Years -	University of California, Davis
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer	NCT05687721	Advanced Urothe...	copanlisib Avelumab	18 Years -	VA Office of Research and Development
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma	NCT05929235	Advanced Solid ... Advanced Urothe... Oral Drug Admin... Open Label	FX-909	18 Years -	Flare Therapeutics Inc.
A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma	NCT04603846	Advanced Urothe...	anti-PD-L1 anti... albumin bound p...	18 Years -	Lee's Pharmaceutical Limited
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma	NCT01071928	Urothelial Carc...	Docetaxel ASA404	18 Years -	Hoosier Cancer Research Network
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer	NCT00942331	Advanced Urothe... Metastatic Blad... Metastatic Pros... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Stage IV Bladde... Stage IV Prosta... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Unresectable Ur...	Bevacizumab Cisplatin Gemcitabine Hyd... Laboratory Biom... Placebo Adminis...	18 Years -	National Cancer Institute (NCI)
Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma	NCT01490437	Urothelial Carc...	Pemetrexed Cisplatin Dexamethasone Vitamins	18 Years - 70 Years	Asan Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: